RecruitingPHASE1, PHASE2NCT07243561

Prospective Clinical Study on Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Childhood Autism

Studying Interatrial communication

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Dongfang People's Hospital
Intervention
hUC-MSC-Exos Nasal Spray(biological)
Enrollment
40 target
Eligibility
3-7 years · All sexes
Timeline
20252026

Study locations (1)

Collaborators

Shanghai Tongjin Stem Cell Technology Co., Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07243561 on ClinicalTrials.gov

Other trials for Interatrial communication

Additional recruiting or active studies for the same condition.

See all trials for Interatrial communication

← Back to all trials